SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001181431-10-037215
Filing Date
2010-07-13
Accepted
2010-07-12 17:41:03
Documents
5
Period of Report
2010-07-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 rrd281196.htm 8-K 14146
2 BRAZZELL rrd281196_32423.htm EX-10.1 59515
3 SCHACHLE rrd281196_32424.htm EX-10.2 59390
4 SPAGNARDI rrd281196_32425.htm EX-10.3 59461
5 STAAB rrd281196_32429.htm EX-10.4 59468
  Complete submission text file 0001181431-10-037215.txt   253201
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31577 | Film No.: 10948852
SIC: 2834 Pharmaceutical Preparations